All In Biotech

Drugs by condition

Drugs approved for irritable bowel syndrome

Brand-name prescription drugs and biologics whose FDA label lists irritable bowel syndrome as an approved use. Matched on the label phrases: "irritable bowel syndrome".

Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

8

Still marketed, NDA or BLA

Drug classes

5

Novel drugs

7

New molecular entities and new biologics

In development

3

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for irritable bowel syndrome.

  • Ibsrela (Tenapanor Hydrochloride) · Ardelyx INC NovelSep 12, 2019
  • Trulance (Plecanatide) · Salix NovelJan 19, 2017
  • Viberzi (Eluxadoline) · Abbvie NovelPriority reviewMay 27, 2015
  • Linzess (Linaclotide) · Abbvie NovelAug 30, 2012
  • Amitiza (Lubiprostone) · Sucampo Pharma LLC NovelJan 31, 2006

All approved drugs for irritable bowel syndrome, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 46 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Guanylate Cyclase-C Agonist (2)

mu-Opioid Receptor Agonist (1)

  • Viberzi Eluxadoline · Abbvie · 2015

Chloride Channel Activator (1)

  • Amitiza Lubiprostone · Sucampo Pharma LLC · 2006

Rifamycin Antibacterial (1)

  • Xifaxan Rifaximin · Salix Pharms · 2004

Class not listed in FDA's data (3)

  • Ibsrela Tenapanor Hydrochloride · Ardelyx INC · 2019
  • Lotronex Alosetron Hydrochloride · Legacy · 2000
  • Librax Chlordiazepoxide Hydrochloride, Clidinium Bromide · Bausch · 1966

Drugs in development for irritable bowel syndrome

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • BrenipatideLY3537031Phase 313 trials

    Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major

  • CamlipixantBLU-5937Phase 34 trials

    GSK · Refractory Chronic Cough, Cough, Irritable Bowel Syndrome

  • TRYP-0082Phase 21 trial

    TRYP Therapeutics · Irritable Bowel Syndrome

More on irritable bowel syndrome: recruiting trials · published research

Related in gastroenterology and liver: MASH (fatty liver disease) · Primary biliary cholangitis · Acid reflux (GERD) · Chronic constipation · Nausea and vomiting · Eosinophilic esophagitis

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.